Royalty Pharma PLC (Class A)

19 oct 2026, 20:07 UTC

Royalty Pharma PLC shares are declining, hitting a midday low after an early peak.

16 oct 2026, 20:02 UTC

Royalty Pharma PLC declared a quarterly dividend of $0.235 per Class A share, payable on December 10, 2026, to shareholders of record as of November 13, 2026.

15 oct 2026, 20:07 UTC

Royalty Pharma PLC shares advanced, supported by broader market strength, while the Health Care Select Sector SPDR ETF reached a record high.

14 oct 2026, 20:02 UTC

Royalty Pharma PLC is advancing during Wednesday's market hours, continuing its upward trajectory since Tuesday's close with unusually high trading volume.

13 oct 2026, 20:02 UTC

Royalty Pharma PLC shares fell sharply, trading near the low end of their one-month range after an initial rebound earlier in the session.

12 oct 2026, 20:06 UTC

Royalty Pharma PLC is advancing, reflecting a strong performance since Friday's close, with today's price peaking in the early afternoon before settling slightly lower.

9 oct 2026, 21:01 UTC

Royalty Pharma PLC shares traded lower in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

8 oct 2026, 20:13 UTC

Royalty Pharma PLC shares advanced modestly during after-market hours on Thursday, holding steady with no notable fluctuations since the market closed.

7 oct 2026, 19:35 UTC

Royalty Pharma PLC shares advanced modestly after Morgan Stanley raised its price target to $67.00 from $65.00 while maintaining an Overweight rating.

6 oct 2026, 20:12 UTC

Royalty Pharma PLC is trading modestly higher in after-market hours, maintaining a steady position below its 20-day moving average and near the lower end of its one-month range.

5 oct 2026, 20:02 UTC

Royalty Pharma PLC shares fell sharply, continuing a downward trend amid broader pharmaceutical sector weakness and reflecting unusually high market volume.

2 oct 2026, 20:07 UTC

Royalty Pharma PLC shares fell sharply, continuing a downward trend and hitting a session low just before market close, significantly below its 20-day moving average.

1 oct 2026, 20:07 UTC

Royalty Pharma PLC shares fell sharply, remaining below their 20-day moving average and positioned near the lower end of their one-month range.

30 sept 2026, 20:20 UTC

Royalty Pharma PLC gained in after-market trading, recovering from a slight loss and marking a significant shift near the lower end of its one-month trading range.

29 sept 2026, 20:07 UTC

Royalty Pharma PLC shares fell modestly, continuing a decline from Monday's close, amid a broader market dip and positioning below the 20-day moving average.

28 sept 2026, 22:06 UTC

Royalty Pharma PLC traded modestly higher in after-market hours, maintaining a stable performance despite being below its 20-day moving average.

24 sept 2026, 19:25 UTC

Royalty Pharma PLC shares are rising, reflecting notable market strength, although they remain below the 20-day moving average and near the one-month range's lower end.

23 sept 2026, 19:51 UTC

Royalty Pharma PLC shares fell sharply, reaching a session low just before 1 PM, as the broader market declines and remains below its 20-day moving average.

22 sept 2026, 20:06 UTC

Royalty Pharma PLC is trading higher, likely influenced by Amgen Inc.'s positive Phase 3 OASIZ 301 study results, despite earlier pulling back from a session high.

21 sept 2026, 20:06 UTC

Royalty Pharma PLC's shares are trading roughly flat, remaining below the 20-day moving average and near the lower end of their one-month range.

18 sept 2026, 20:06 UTC

Royalty Pharma PLC shares fell sharply on Friday, closing significantly below its 20-day moving average and near the lower end of its one-month range.

17 sept 2026, 23:06 UTC

Royalty Pharma PLC declined in after-market trading, moving lower since Thursday's close and positioning it below its 20-day moving average.

16 sept 2026, 23:06 UTC

Royalty Pharma PLC is trading lower in after-market hours, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

15 sept 2026, 23:16 UTC

Royalty Pharma announced a $7.5 million donation to Blood Cancer United. Shares are lower in after-market trading amid rising Treasury yields.

14 sept 2026, 20:07 UTC

Royalty Pharma PLC shares are higher today, reflecting a modest gain since Friday. Broader market concerns over rising crude oil prices may be influencing sentiment.

11 sept 2026, 20:08 UTC

Royalty Pharma PLC shares are lower today, pulling back from earlier gains amid broader market dynamics and inflation pressures influencing Federal Reserve policy.

10 sept 2026, 23:46 UTC

Royalty Pharma PLC shares are higher in after-market trading, continuing a rise since Thursday's close, though still below the 20-day moving average.

9 sept 2026, 20:07 UTC

Royalty Pharma shares lower today, following a decline after Novartis' trial failure. Analysts suggest the drop may be overdone amid stable royalty expectations.

8 sept 2026, 21:01 UTC

Royalty Pharma PLC shares are higher in after-market hours, reflecting broader market dynamics despite no specific company news identified.

5 sept 2026, 00:01 UTC

Royalty Pharma PLC shares fell in after-market hours following the failed Phase 3 trial of pelacarsen, impacting its funding agreement with Ionis.